Developer docs
API playgroundTry for free, no card

Search company profiles

Cross Pharmaceuticals

Full company profile

uuid0023gxx

Namestring
Cross Pharmaceuticals
Legal namestring
CROSS ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΙΑ ΙΔΙΩΤΙΚΗ ΚΕΦΑΛΑΙΟΥΧΙΚΗ ΕΤΑΙΡΙΑ
Websiteurl
crosspharma.gr
Company typeenum
Private
Founded yearint
1975
Descriptiontext

Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975 and headquartered in Thessaloniki, with a regional branch in Athens. The company operates a diversified healthcare portfolio spanning prescription medicines (Rx), over-the-counter (OTC) products, food supplements, medical devices, and dermocosmetics, with therapeutic focus on dermatology, anti-infectives, blood disorders, and women's health. Proprietary technology elements include the CEL BIOtechnology liposomal gel delivery platform and the GynoBiome vaginal microbiome restoration line, complemented by branded consumer franchises such as IZICOL, Izicol Junior, FertilU, Lactobiome, and Synergeia. The company holds ISO 9001 quality certification and operates under Greek National Organization for Medicines (EOF) regulatory oversight, with established pharmacovigilance practices.

The business operates through a hybrid B2B/B2C go-to-market model. B2B distribution flows through the Greek pharmacy network, a physician registration portal for accessing prescription product information and pricing, and direct supply to hospitals and rehabilitation centers. B2C channels include the company website (crosspharma.gr) with e-commerce functionality in Greek, English, and Spanish, alongside social media engagement. The website uses a login-based pricing model, consistent with registered-user B2B transactions rather than transparent consumer pricing.

Cross Pharmaceuticals self-identifies as one of the top five fastest-growing pharmaceutical companies in Greece and as having 50 years of pharmaceutical pioneering in the domestic market. Geographic operations remain concentrated in Greece with no disclosed export markets, though the multilingual website and CSR-driven institutional relationships suggest exploratory international and institutional positioning. No external funding rounds, parent company, or institutional investors are disclosed, indicating founder/management-controlled ownership under Greek private capital company (I.K.E.) structure.

Short descriptiontext

Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975, headquartered in Thessaloniki, that develops and distributes prescription medicines, OTC products, food supplements, medical devices, and dermocosmetics across dermatology, anti-infectives, blood disorders, and women's health for Greek pharmacies, physicians, and consumers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersThérmi, Greece
HQ citystring
Thérmi
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prescription pharmaceuticals, OTC medicines, dermatological products, food supplements, medical devices
Industry5 codes
PRIMARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Prescription Medicines (Rx)
TypeOne Time License
Description

Prescription pharmaceutical products including anti-infectives, blood disease medications, and dermatological treatments sold through pharmacies and healthcare providers

crosspharma.gr
2OTC and Non-Prescription Medicines
TypeOne Time License
Description

Non-prescription dermatological medicines, oral cavity treatments, and medical devices available for direct consumer purchase

crosspharma.gr
3Pharmaceutical Products
TypeOne Time License
Description

Food supplements, medical technology products, and liposomal technology gels (CEL BIOtechnology) for consumer health and wellness

crosspharma.gr
4Corporate Social Responsibility Donations
TypeProfessional Services
Description

Donation of pharmaceutical and parapharmaceutical products to healthcare institutions as part of CSR initiatives

crosspharma.gr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1IZICOL
Description

Brand of pharmaceutical products

crosspharma.gr
+7 more records
Core offering1 text field

Cross Pharmaceuticals manufactures and distributes a diversified pharmaceutical portfolio in Greece, including prescription medicines (anti-infectives, blood disease and dermatological treatments), OTC/non-prescription medicines, food supplements, medical devices, and dermocosmetics under brands such as IZICOL, FertilU, GynoBiome, Lactobiome, Jomezal, CEL, and Synergeia. The company focuses on dermatology, anti-infectives, blood disorders, and women's health, utilizing proprietary CEL BIOtechnology liposomal gels for enhanced delivery of active ingredients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cross Pharmaceuticals is a Greek pharmaceutical company with 50 years of experience, operating from 'Cure to Care' - expanding from pharmaceutical treatments to comprehensive healthcare. The company offers a diversified portfolio comprising prescription medicines (Rx) including corticosteroids for skin diseases (Momecort Cream), non-steroidal anti-inflammatory drugs (Jomezal), anti-infective medicines, and medicines for blood diseases. The non-prescription (OTC) portfolio includes dermatological medicines and medicines for oral cavity diseases. Para-pharmaceutical products include GynoBiome (vaginal microbiome restoration), FertilU (fertility support), Lactobiome (probiotics), and CEL BIOtechnology liposomal technology gels for advanced drug delivery. The company also markets brands including IZICOL, Izicol Junior, and Synergeia.

Product and service11 records
1Momecort Cream
CategoryPrescription Medicine (Rx) - Dermatological
Description

Corticosteroid dermatological prescription medicine used for skin conditions, intended for prescribing physicians and patients with dermatological conditions.

2Jomezal
CategoryNon-prescription Medicine (OTC) - Anti-inflammatory
Description

Non-prescription non-steroidal anti-inflammatory drug used for conditions of the oral cavity and skin diseases, available for direct consumer purchase.

3GynoBiome
CategoryPharmaceutical Product - Women's Health
Description

Pharmaceutical product for vaginal microbiome restoration, addressing gynecological and women's health needs.

4FertilU
CategoryPharmaceutical Product - Fertility
Description

Pharmaceutical product that improves conception conditions, supporting fertility and reproductive health for women seeking reproductive wellness.

5Lactobiome
CategoryPharmaceutical Product - Probiotics
Description

Probiotic pharmaceutical product within the Cross Pharmaceuticals portfolio, supporting microbiome health.

6CEL BIOtechnology Liposomal Gels
CategoryPharmaceutical Product - Liposomal Delivery Technology
Description

Para-pharmaceutical liposomal technology gels for advanced delivery of active ingredients, utilizing CEL BIOtechnology as a differentiated delivery platform.

7Anti-infective Medicines
CategoryPrescription Medicine (Rx) - Anti-infectives
Description

Prescription medicines category covering anti-infective medications for the treatment of infections.

8Medicines for Blood Diseases
CategoryPrescription Medicine (Rx) - Hematology
Description

Prescription medicines category covering treatments for hematological/blood disease conditions.

9Medicines for Skin Diseases
CategoryPrescription Medicine (Rx) - Dermatology
Description

Prescription medicines category covering dermatological treatments for skin diseases.

10Medical Technology Products
CategoryMedical Device / Parapharmaceutical
Description

Para-pharmaceutical category covering medical devices and medical technology products.

11Food Supplements
CategoryFood Supplements / Parapharmaceutical
Description

Para-pharmaceutical nutritional and dietary supplements supporting consumer health and wellness.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Greek pharmaceutical manufacturer producing generics, OTC products, and food supplements for the Greek market. Directly comparable in scale, product mix, and pharmacy distribution model.

TypeDirect peer
Description

Greek pharmaceutical company offering Rx, OTC, food supplements, and dermocosmetics distributed through Greek pharmacies. Direct overlap with Cross in prescription dermatology and consumer health categories.

TypeDirect peer
Description

Greek pharmaceutical manufacturer with branded generics, OTC, and consumer health products across dermatology and specialty care. Comparable mid-cap size and Greek-domestic pharmacy distribution.

TypeBroad incumbent
Description

Established Greek pharmaceutical and consumer healthcare company with a broader branded generics, OTC, and personal care portfolio. Comparable in dermocosmetics and OTC distribution but larger and more diversified.

TypeDirect peer
Description

Greek pharmaceutical manufacturer founded in Athens with a similar portfolio of branded generics, specialty pharma, and OTC products distributed through Greek pharmacies and hospitals. Closely comparable in scale, therapeutic focus, and Greek-domestic go-to-market.

TypeDirect peer
Description

Greek specialty pharmaceutical manufacturer focused on Rx generics across dermatology, CNS, and women's health. Comparable therapeutic categories and Greek-domestic B2B sales motion via pharmacies and hospitals.

TypeBroad incumbent
Description

Global dermocosmetics leader (La Roche-Posay, Vichy, CeraVe) competing in the same medical-grade skincare and dermatology categories Cross addresses with its CEL BIOtechnology line. Represents the multinational competitive benchmark for Cross's dermocosmetic ambitions.

TypeDirect peer
Description

One of the largest Greek pharmaceutical manufacturers, producing sterile injectables, generics, and specialty pharma with both Greek and export presence. Comparable product categories (injectable and topical Rx) and overlapping dermatology/women's health portfolios.

TypeDirect peer
Description

Greek pharmaceutical company producing branded generics, specialty pharmaceuticals, and consumer health products for the domestic and select export markets. Comparable in mid-cap size, OTC/Rx mix, and Greek-domestic distribution model.

TypeDirect peer
Description

Greek specialty pharma company commercializing branded pharmaceuticals in therapeutic areas including dermatology, women's health, and specialty care. Closely aligned with Cross's therapeutic focus and physician-channel GTM.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cross Pharmaceuticals

Pharmaceuticalscrosspharma.gr

Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975, headquartered in Thessaloniki, that develops and distributes prescription medicines, OTC products, food supplements, medical devices, and dermocosmetics across dermatology, anti-infectives, blood disorders, and women's health for Greek pharmacies, physicians, and consumers.

What Cross Pharmaceuticals does

Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975 and headquartered in Thessaloniki, with a regional branch in Athens. The company operates a diversified healthcare portfolio spanning prescription medicines (Rx), over-the-counter (OTC) products, food supplements, medical devices, and dermocosmetics, with therapeutic focus on dermatology, anti-infectives, blood disorders, and women's health. Proprietary technology elements include the CEL BIOtechnology liposomal gel delivery platform and the GynoBiome vaginal microbiome restoration line, complemented by branded consumer franchises such as IZICOL, Izicol Junior, FertilU, Lactobiome, and Synergeia. The company holds ISO 9001 quality certification and operates under Greek National Organization for Medicines (EOF) regulatory oversight, with established pharmacovigilance practices.

The business operates through a hybrid B2B/B2C go-to-market model. B2B distribution flows through the Greek pharmacy network, a physician registration portal for accessing prescription product information and pricing, and direct supply to hospitals and rehabilitation centers. B2C channels include the company website (crosspharma.gr) with e-commerce functionality in Greek, English, and Spanish, alongside social media engagement. The website uses a login-based pricing model, consistent with registered-user B2B transactions rather than transparent consumer pricing.

Cross Pharmaceuticals self-identifies as one of the top five fastest-growing pharmaceutical companies in Greece and as having 50 years of pharmaceutical pioneering in the domestic market. Geographic operations remain concentrated in Greece with no disclosed export markets, though the multilingual website and CSR-driven institutional relationships suggest exploratory international and institutional positioning. No external funding rounds, parent company, or institutional investors are disclosed, indicating founder/management-controlled ownership under Greek private capital company (I.K.E.) structure.

Cross Pharmaceuticals firmographics

Firmographics
Name
Cross Pharmaceuticals
Legal name
CROSS ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΙΑ ΙΔΙΩΤΙΚΗ ΚΕΦΑΛΑΙΟΥΧΙΚΗ ΕΤΑΙΡΙΑ
Website
https://crosspharma.gr
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
51–100 employees
Short description
Cross Pharmaceuticals is a privately held Greek pharmaceutical company founded in 1975, headquartered in Thessaloniki, that develops and distributes prescription medicines, OTC products, food supplements, medical devices, and dermocosmetics across dermatology, anti-infectives, blood disorders, and women's health for Greek pharmacies, physicians, and consumers.
Ownership category
akta.pro rank

Cross Pharmaceuticals industry classification

Industry
Product category
Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements

Keywords

  • Prescription pharmaceuticals
  • OTC medicines
  • Dermatological products
  • Food supplements
  • Medical devices

Where Cross Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Thérmi
HQ country
Greece
HQ region
Europe

Offices2 records

Markets served

Cross Pharmaceuticals business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Prescription Medicines (Rx): Prescription pharmaceutical products including anti-infectives, blood disease medications, and dermatological treatments sold through pharmacies and healthcare providers
  2. OTC and Non-Prescription Medicines: Non-prescription dermatological medicines, oral cavity treatments, and medical devices available for direct consumer purchase
  3. Pharmaceutical Products: Food supplements, medical technology products, and liposomal technology gels (CEL BIOtechnology) for consumer health and wellness
  4. Corporate Social Responsibility Donations: Donation of pharmaceutical and parapharmaceutical products to healthcare institutions as part of CSR initiatives

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Cross Pharmaceuticals product offering

Product offering

Core offering

Cross Pharmaceuticals manufactures and distributes a diversified pharmaceutical portfolio in Greece, including prescription medicines (anti-infectives, blood disease and dermatological treatments), OTC/non-prescription medicines, food supplements, medical devices, and dermocosmetics under brands such as IZICOL, FertilU, GynoBiome, Lactobiome, Jomezal, CEL, and Synergeia. The company focuses on dermatology, anti-infectives, blood disorders, and women's health, utilizing proprietary CEL BIOtechnology liposomal gels for enhanced delivery of active ingredients.

Product overview

Cross Pharmaceuticals is a Greek pharmaceutical company with 50 years of experience, operating from 'Cure to Care' - expanding from pharmaceutical treatments to comprehensive healthcare. The company offers a diversified portfolio comprising prescription medicines (Rx) including corticosteroids for skin diseases (Momecort Cream), non-steroidal anti-inflammatory drugs (Jomezal), anti-infective medicines, and medicines for blood diseases. The non-prescription (OTC) portfolio includes dermatological medicines and medicines for oral cavity diseases. Para-pharmaceutical products include GynoBiome (vaginal microbiome restoration), FertilU (fertility support), Lactobiome (probiotics), and CEL BIOtechnology liposomal technology gels for advanced drug delivery. The company also markets brands including IZICOL, Izicol Junior, and Synergeia.

Differentiator

Problem solved

Functional benefit

Brands

  • IZICOL: Brand of pharmaceutical products
  • IZICOL Junior
  • FertilU
  • CEL
  • GynoBiome
  • Lactobiome
  • Jomezal
  • Synergeia

Products and services

  • Momecort Cream Corticosteroid dermatological prescription medicine used for skin conditions, intended for prescribing physicians and patients with dermatological conditions.
  • Jomezal Non-prescription non-steroidal anti-inflammatory drug used for conditions of the oral cavity and skin diseases, available for direct consumer purchase.
  • GynoBiome Pharmaceutical product for vaginal microbiome restoration, addressing gynecological and women's health needs.
  • FertilU Pharmaceutical product that improves conception conditions, supporting fertility and reproductive health for women seeking reproductive wellness.
  • Lactobiome Probiotic pharmaceutical product within the Cross Pharmaceuticals portfolio, supporting microbiome health.
  • CEL BIOtechnology Liposomal Gels Para-pharmaceutical liposomal technology gels for advanced delivery of active ingredients, utilizing CEL BIOtechnology as a differentiated delivery platform.
  • Anti-infective Medicines Prescription medicines category covering anti-infective medications for the treatment of infections.
  • Medicines for Blood Diseases Prescription medicines category covering treatments for hematological/blood disease conditions.
  • Medicines for Skin Diseases Prescription medicines category covering dermatological treatments for skin diseases.
  • Medical Technology Products Para-pharmaceutical category covering medical devices and medical technology products.
  • Food Supplements Para-pharmaceutical nutritional and dietary supplements supporting consumer health and wellness.

Companies that use Cross Pharmaceuticals

Customer profile

Segments5 records

Ideal customer profiles4 records

Cross Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Cross Pharmaceuticals partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Cross Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Galenica: Greek pharmaceutical manufacturer producing generics, OTC products, and food supplements for the Greek market. Directly comparable in scale, product mix, and pharmacy distribution model.
  • Help Pharmaceuticals: Greek pharmaceutical company offering Rx, OTC, food supplements, and dermocosmetics distributed through Greek pharmacies. Direct overlap with Cross in prescription dermatology and consumer health categories.
  • Vianex: Greek pharmaceutical manufacturer with branded generics, OTC, and consumer health products across dermatology and specialty care. Comparable mid-cap size and Greek-domestic pharmacy distribution.
  • ELPEN Pharmaceutical: Greek pharmaceutical manufacturer founded in Athens with a similar portfolio of branded generics, specialty pharma, and OTC products distributed through Greek pharmacies and hospitals. Closely comparable in scale, therapeutic focus, and Greek-domestic go-to-market.
  • Uni-Pharma: Greek specialty pharmaceutical manufacturer focused on Rx generics across dermatology, CNS, and women's health. Comparable therapeutic categories and Greek-domestic B2B sales motion via pharmacies and hospitals.
  • Demo S.A. One of the largest Greek pharmaceutical manufacturers, producing sterile injectables, generics, and specialty pharma with both Greek and export presence. Comparable product categories (injectable and topical Rx) and overlapping dermatology/women's health portfolios.
  • Rafarm: Greek pharmaceutical company producing branded generics, specialty pharmaceuticals, and consumer health products for the domestic and select export markets. Comparable in mid-cap size, OTC/Rx mix, and Greek-domestic distribution model.
  • Genesis Pharma: Greek specialty pharma company commercializing branded pharmaceuticals in therapeutic areas including dermatology, women's health, and specialty care. Closely aligned with Cross's therapeutic focus and physician-channel GTM.

Broad incumbents

  • Lavipharm: Established Greek pharmaceutical and consumer healthcare company with a broader branded generics, OTC, and personal care portfolio. Comparable in dermocosmetics and OTC distribution but larger and more diversified.
  • L'Oréal Dermatological Beauty: Global dermocosmetics leader (La Roche-Posay, Vichy, CeraVe) competing in the same medical-grade skincare and dermatology categories Cross addresses with its CEL BIOtechnology line. Represents the multinational competitive benchmark for Cross's dermocosmetic ambitions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Cross Pharmaceuticals social profiles

Digital presence

Cross Pharmaceuticals compliance and trust

Trust signal

Compliance1 record

Cross Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cross Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Cross Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cross Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cross Pharmaceuticals

What does Cross Pharmaceuticals do?

Cross Pharmaceuticals manufactures and distributes a diversified pharmaceutical portfolio in Greece, including prescription medicines (anti-infectives, blood disease and dermatological treatments), OTC/non-prescription medicines, food supplements, medical devices, and dermocosmetics under brands such as IZICOL, FertilU, GynoBiome, Lactobiome, Jomezal, CEL, and Synergeia. The company focuses on dermatology, anti-infectives, blood disorders, and women's health, utilizing proprietary CEL BIOtechnology liposomal gels for enhanced delivery of active ingredients.

Is Cross Pharmaceuticals a public or private company?

Cross Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cross Pharmaceuticals founded?

Cross Pharmaceuticals was founded in 1975. It employs 51 to 100 people.

Where is Cross Pharmaceuticals based?

Cross Pharmaceuticals is headquartered in Thérmi, Greece, in the Europe region.

How does Cross Pharmaceuticals make money?

Four revenue lines are on record. Prescription Medicines (Rx) is the primary driver. The others are OTC and Non-Prescription Medicines, pharmaceutical Products and corporate Social Responsibility Donations.

Who are Cross Pharmaceuticals's main competitors?

Direct peers on record are Galenica, Help Pharmaceuticals, Vianex, ELPEN Pharmaceutical, Uni-Pharma, Demo S.A., Rafarm and Genesis Pharma. Broad incumbents are Lavipharm and L'Oréal Dermatological Beauty.

Does Cross Pharmaceuticals have an API?

No public API is recorded for Cross Pharmaceuticals.

What industry is Cross Pharmaceuticals in?

Cross Pharmaceuticals's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIACAL, Dermatology Specialty Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales